Apyx Medical Corp [NASDAQ: APYX] gained 42.99% or 0.47 points to close at $1.58 with a heavy trading volume of 7770621 shares.
The daily chart for APYX points out that the company has recorded 29.51% gains over the past six months.
If we look at the average trading volume of 52.10K shares, APYX reached to a volume of 7770621 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Apyx Medical Corp [APYX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APYX shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APYX stock is a recommendation set at 2.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Apyx Medical Corp shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 17, 2024. While these analysts kept the previous recommendation, Stephens raised their target price to Overweight. The new note on the price target was released on July 14, 2023, representing the official price target for Apyx Medical Corp stock. Previously, the target price had yet another raise to $12, while Lake Street analysts kept a Buy rating on APYX stock. On April 02, 2019, analysts decreased their price target for APYX shares from 12 to 9.
The Average True Range (ATR) for Apyx Medical Corp is set at 0.18, with the Price to Sales ratio for APYX stock in the period of the last 12 months amounting to 1.26. The Price to Book ratio for the last quarter was 5.68, with the Price to Cash per share for the same quarter was set at 0.82.
Trading performance analysis for APYX stock
Apyx Medical Corp [APYX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 47.66. With this latest performance, APYX shares gained by 64.93% in over the last four-week period, additionally plugging by 29.51% over the last 6 months – not to mention a drop of -4.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APYX stock in for the last two-week period is set at 68.29, with the RSI for the last a single of trading hit 73.65, and the three-weeks RSI is set at 63.87 for Apyx Medical Corp [APYX]. The present Moving Average for the last 50 days of trading for this stock 1.1063, while it was recorded at 1.2550 for the last single week of trading, and 1.3000 for the last 200 days.
Apyx Medical Corp [APYX]: A deeper dive into fundamental analysis
Apyx Medical Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.64 and a Current Ratio set at 5.45.
Apyx Medical Corp [APYX]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APYX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Apyx Medical Corp go to 20.65%.
An analysis of Institutional ownership at Apyx Medical Corp [APYX]
There are presently around $43.81%, or 51.28%% of APYX stock, in the hands of institutional investors. The top three institutional holders of APYX stocks are: ARCHON CAPITAL MANAGEMENT LLC with ownership of 3.12 million shares, which is approximately 8.9923%. ROYCE & ASSOCIATES LP, holding 2.5 million shares of the stock with an approximate value of $$3.35 million in APYX stocks shares; and ROYCE & ASSOCIATES LP, currently with $$1.98 million in APYX stock with ownership which is approximately 4.2746%.
